Skip to menu Skip to content Skip to footer

2020

Journal Article

“It ain't over … till it's over!” Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic

Holtmann, Gerald, Quigley, Eamonn M., Shah, Ayesha, Camilleri, Michael, Tan, Victoria P.Y., Gwee, Kok Ann, Sugano, Kentaro, Sollano, Jose D., Fock, Kwong M., Ghoshal, Uday C., Chen, Minhu, Dignass, Axel and Cohen, Henry (2020). “It ain't over … till it's over!” Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic. Journal of Gastroenterology and Hepatology, 35 (7), 1117-1123. doi: 10.1111/jgh.15133

“It ain't over … till it's over!” Risk-mitigation strategies for patients with gastrointestinal diseases in the aftermath of the COVID-19 pandemic

2020

Conference Publication

Self-reported non-celiac wheat sensitivity (NCWS) in patients with chronic unexplained (functional) gastrointestinal symptoms

Shah, Ayesha, Talley, Nicholas, Kang, Seungha, Do, Anh, Walker, Marjorie, Koloski, Natasha, Jones, Michael, Keely, Simon, Morrison, Mark and Holtmann, Gerald (2020). Self-reported non-celiac wheat sensitivity (NCWS) in patients with chronic unexplained (functional) gastrointestinal symptoms. Meeting of the Federation of Neurogastroenterology and Motility, Adelaide, SA Australia, 25 – 28 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Self-reported non-celiac wheat sensitivity (NCWS) in patients with chronic unexplained (functional) gastrointestinal symptoms

2020

Conference Publication

Variations of the mucosa associated microbiota along the human gastrointestinal tract in health and inflammatory bowel disease

Shah, Ayesha, Kang, Seungha, Tyson, Gene, Zaugg, Julian, Hugenholtz, Phil, Morrison, Mark and Holtmann, Gerald J. (2020). Variations of the mucosa associated microbiota along the human gastrointestinal tract in health and inflammatory bowel disease. Crohn's and Colitis Congress, Austin, TX, United States, 23-25 January 2020. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(20)32052-7

Variations of the mucosa associated microbiota along the human gastrointestinal tract in health and inflammatory bowel disease

2020

Journal Article

Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet

Daveson, A. James M., Popp, Alina, Taavela, Juha, Goldstein, Kaela E., Isola, Jorma, Truitt, Kenneth E., Mäki, Markku, Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Chen Yi Mei, S., Coates, A., Daveson, A.J., DiMarino, A., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R., Holtmann, G., Idarraga, S. ... Wilson, S. (2020). Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet. GastroHep, 2 (1), 22-30. doi: 10.1002/ygh2.380

Baseline quantitative histology in therapeutics trials reveals villus atrophy in most patients with coeliac disease who appear well controlled on gluten‐free diet

2019

Conference Publication

Functional Gastrointestinal Disorders (FGIDs) patients benefit from a 12-weeks multidisciplinary integrated treatment approach to reduce gastrointestinal symptoms, anxiety and depressive symptoms

Bray, Nicola, Koloski, Natasha, Jones, Michael, Do, Anh, Talley, Nicholas, Billin, Abbi, Bettens, Gemma, Mcallister, Sarah, Pang, Siong, Arthur, Leela, Campos, Jane, Chao, Jeff and Holtmann, Gerald (2019). Functional Gastrointestinal Disorders (FGIDs) patients benefit from a 12-weeks multidisciplinary integrated treatment approach to reduce gastrointestinal symptoms, anxiety and depressive symptoms. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), Adelaide, SA, Australia, 8–10 September 2019. Hoboken, NJ, United States: Wiley-Blackwell.

Functional Gastrointestinal Disorders (FGIDs) patients benefit from a 12-weeks multidisciplinary integrated treatment approach to reduce gastrointestinal symptoms, anxiety and depressive symptoms

2019

Conference Publication

Diagnostic yield and healthcare resource utilization of Eesophagogastroduodenoscopy in patients referred for colonoscopy for investigation of positive Fecal Occult Blood Test (FOBT plus )

Shah, Ayesha, Kutyla, Marguerite, Hansen, Teressa, Virgo, Kate, Koloski, Natasha, Huelsen-Katz, Alexander, Martin, Neal, Maqboul, Nadia, Chao, Che-Yung, Whaley, Amanda, Hourigan, Luke and Holtmann, Gerald (2019). Diagnostic yield and healthcare resource utilization of Eesophagogastroduodenoscopy in patients referred for colonoscopy for investigation of positive Fecal Occult Blood Test (FOBT plus ). Asia Pacific Digestive Week (APDW), Kolkata, India, 12–15 December 2019. Richmond, VIC Australia: John Wiley & Sons.

Diagnostic yield and healthcare resource utilization of Eesophagogastroduodenoscopy in patients referred for colonoscopy for investigation of positive Fecal Occult Blood Test (FOBT plus )

2019

Journal Article

Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease

Daveson, A. James M., Tye-Din, Jason A., Goel, Gautam, Goldstein, Kaela E., Hand, Holly L., Neff, Kristin M., Williams, Leslie J., Truitt, Kenneth E., Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Mei, S. Chen Yi, Coates, A., Daveson, A. J. M., DiMarino, A., Ee, H., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R. ... Wilson, S. (2019). Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary Pharmacology & Therapeutics, 51 (2), 244-252. doi: 10.1111/apt.15551

Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease

2019

Conference Publication

A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom reduction in patients with functional gastrointestinal disorders: A case-control study

Bray, N., Koloski, N., Jones, M., Do, A., Talley, N., Billin, A., Bettens, G., McAllister, S., Pang, S., Arthur, L., Campos, J., Chao, C., Catague, R., Whalley, A., MacDonald, G. and Holtmann, G. (2019). A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom reduction in patients with functional gastrointestinal disorders: A case-control study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), Adelaide, SA, Australia, 8–10 September 2019. Hoboken, NJ, United States: Wiley-Blackwell.

A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom reduction in patients with functional gastrointestinal disorders: A case-control study

2019

Conference Publication

A hospital-based, multidisciplinary approach to lifestyle management is effective in patients with non-alcoholic fatty liver disease

Britton, L., Stewart, A., Campos, J., Robertson, T., Mcallister, S., De Maria, K., Catague, R., Wright, P., Holtmann, G. and MacDonald, G. (2019). A hospital-based, multidisciplinary approach to lifestyle management is effective in patients with non-alcoholic fatty liver disease. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, SA, Australia, 8–10 September 2019. Richmond, VIC, Australia: Wiley-Blackwell.

A hospital-based, multidisciplinary approach to lifestyle management is effective in patients with non-alcoholic fatty liver disease

2019

Conference Publication

Patients with functional gastrointestinal disorders benefit from a 12-week multidisciplinary integrated treatment approach to reduce anxiety and depressive symptoms

Bray, N., Koloski, N., Jones, M., Do, A., Talley, N., Billin, A., Bettens, G., Mcallister, S., Pang, S., Arthur, L., Campus, J., Chao, C., Catague, R., Whaley, A., Macdonald, G. and Holtmann, G. (2019). Patients with functional gastrointestinal disorders benefit from a 12-week multidisciplinary integrated treatment approach to reduce anxiety and depressive symptoms. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), Adelaide, SA, Australia, 8–10 September 2019. Hoboken, NJ, United States: Wiley-Blackwell.

Patients with functional gastrointestinal disorders benefit from a 12-week multidisciplinary integrated treatment approach to reduce anxiety and depressive symptoms

2019

Journal Article

The use of modelling studies to inform planning of health services: case study of rapidly increasing endoscopy services in Australia

Carter, Hannah E., Knowles, Dylan, Moroney, Timothy, Holtmann, Gerald, Rahma, Tony, Appleyard, Mark, Steele, Nick, Zanco, Michael and Graves, Nicholas (2019). The use of modelling studies to inform planning of health services: case study of rapidly increasing endoscopy services in Australia. BMC Health Services Research, 19 (1) 608, 608. doi: 10.1186/s12913-019-4438-x

The use of modelling studies to inform planning of health services: case study of rapidly increasing endoscopy services in Australia

2019

Journal Article

Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease

Raj, Ashok S., Shanahan, Erin R., Tran, Cuong D., Bhat, Purnima, Fletcher, Linda M., Vesey, David A., Morrison, Mark, Holtmann, Gerald and Macdonald, Graeme A. (2019). Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease. Clinical and Translational Gastroenterology, 10 (8) e00068, e00068. doi: 10.14309/ctg.0000000000000068

Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease

2019

Journal Article

Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome

Talley, Nicholas J., Holtmann, Gerald, Walker, Marjorie M., Burns, Grace, Potter, Michael, Shah, Ayesha, Jones, Michael, Koloski, Natasha A. and Keely, Simon (2019). Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome. Clinical and Translational Gastroenterology, 10 (7) e-00064, e00064. doi: 10.14309/ctg.0000000000000064

Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome

2019

Conference Publication

In-vitro evaluation of antifoaming effects of simethicone: a dose-finding study

Kutyla, Marguerite, Shah, Ayesha, Meeusen, Vera, Elson, Jerome, Heulsen-Katz, Alex, Hourigan, Luke F. and Holtmann, Gerald J. (2019). In-vitro evaluation of antifoaming effects of simethicone: a dose-finding study. Digestive Disease Week (DDW), San Diego, CA United States, 18-21 May 2019. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.gie.2019.03.070

In-vitro evaluation of antifoaming effects of simethicone: a dose-finding study

2019

Journal Article

An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy

Kutyla, Marguerite J., Shah, Ayesha, Elson, Jerome, Meeusen, Vera, O’Connor, Sam, Hourigan, Luke F. and Holtmann, Gerald J. (2019). An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy. Indian Journal of Gastroenterology, 38 (3), 268-272. doi: 10.1007/s12664-019-00966-3

An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy

2019

Conference Publication

Weight loss and metabolic improvements one year after treatment with a duodenal-jejunal bypass sleeve (Endobarrier (R))

McMaster, Jessica J., Shanahan, Erin R., Anh Do,, Rich, Graeme, Veronique, Chachay, Macdonald, Graeme A. and Holtmann, Gerald J. (2019). Weight loss and metabolic improvements one year after treatment with a duodenal-jejunal bypass sleeve (Endobarrier (R)). Digestive Disease Week (DDW), San Diego, CA USA, 18-21 May 2019. Philadelphia, PA USA: Elsevier.

Weight loss and metabolic improvements one year after treatment with a duodenal-jejunal bypass sleeve (Endobarrier (R))

2019

Journal Article

Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease

Shah, Ayesha, Morrison, Mark, Burger, Daniel, Martin, Neal, Rich, Justin, Jones, Mike, Koloski, Natasha, Walker, Marjorie M., Talley, Nicholas J. and Holtmann, Gerald J. (2019). Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 49 (6), 624-635. doi: 10.1111/apt.15133

Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease

2019

Journal Article

Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress

Koloski, Natasha, Jones, Michael, Walker, Marjorie M., Veysey, Martin, Zala, Alkesh, Keely, Simon, Holtmann, Gerald and Talley, Nicholas J. (2019). Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress. Alimentary Pharmacology and Therapeutics, 49 (5), 546-555. doi: 10.1111/apt.15120

Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress

2019

Journal Article

The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data 11 Medical and Health Sciences 1103 Clinical Sciences

Alammar, N., Wang, L., Saberi, B., Nanavati, J., Holtmann, G., Shinohara, R. T. and Mullin, G. E. (2019). The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data 11 Medical and Health Sciences 1103 Clinical Sciences. BMC Complementary and Alternative Medicine, 19 (1) 21, 21. doi: 10.1186/s12906-018-2409-0

The impact of peppermint oil on the irritable bowel syndrome: A meta-analysis of the pooled clinical data 11 Medical and Health Sciences 1103 Clinical Sciences

2019

Conference Publication

273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study

Bray, Nicola, Koloski, Natasha A., Jones, Michael P., Do, Anh, Talley, Nicholas J., McAllister, Sarah, Pang, Siong, Arthur, Leela, Campos, Jane, Chao, Che-yung, Billin, Abi, Bettens, Gemma, Catague, Rachel, Whaley, Amanda, Macdonald, Graeme A. and Holtmann, Gerald J. (2019). 273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study. Digestive Disease Week 2019, San Diego, CA, United States, 18-21 May 2019. PHILADELPHIA: Elsevier BV. doi: 10.1016/s0016-5085(19)36917-3

273 – A Multidisciplinary Integrated Treatment Approach is Superior to Standard Care for Functional Gastrointestinal Disorders (FGIDS): A Case-Control Study